Long-term follow-up of prolactinomas: Normoprolactinemia after bromocriptine withdrawal

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 8, 2002, Pages 3578-3582

  Passos, Vanessa Q ^a   Souza, Jean J S ^a   Musolino, Nina R C ^a   Bronstein, Marcello D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE;

ADOLESCENT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; TREATMENT OUTCOME;

MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 0036348485     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.8.8722     Document Type: Article

References (23)

1. Medical treatment of prolactinomas
2. Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine
3. Rapid re-expansion of a macroprolactinoma after early discontinuation of bromocriptine
4. Prolactin secretion and menstrual function after long-term bromocriptine treatment
5. Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerized tomography
6. Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size
7. Long-term treatment of hyperprolactinaemia with bromocriptine: Effect of drug withdrawal
8. Impaired regulation of prolactin in patients with persisting normoprolactinaemia after withdrawal of long-term therapy with dopamine agonists
9. Follow-up of patients with prolactinomas after discontinuation of long-term therapy with bromocriptine
10. D2 dopaminergic receptors: Normal and abnormal transduction mechanisms
11. Perivascular fibrosis in prolactinomas: Is it increased by bromocriptine?
12. Bromocriptine treatment reduces the cell size in human macroprolactinomas: A morphometric study
13. Management of prolactinomas
14. Human prolactin-producing adenomas and bromocriptine: A histological, immunocytochemical, ultrastructural, and morphometric study
15. Necrotic changes in prolactinomas after long term administration of bromocriptine
16. Long-term follow-up of patients with hyperprolactinaemia
17. Pituitary prolactinomas
18. Treatment of prolactinomas with megavoltage radiotherapy
19. The effect of the menopause on prolactin levels in patients with hyperprolactinaemia
20. Hyperprolactinemia, amenorrhea, and galactorrhea. A retrospective assessment of twenty-five cases
21. The natural history of untreated hyperprolactinemia: A prospective analysis
22. The natural history of idiopathic hyperprolactinemia
23. The natural history of untreated microprolactinomas